AGER and COVID-19: In conclusion, our study demonstrates the potential prognostic value of two emerging biomarkers predictive of development of severe disease in patients presenting to the emergency department for symptomatic COVID-19: RAGE and the SARS-COV-2 nucleocapsid viral antigen.